Putnam BioRevolution ETF Rating $30.63 +0.52 (+1.73%) As of 01/21/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsRatings Putnam BioRevolution ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SYNB Aggregate RatingModerate Buy 2.79Holdings in SYNB have an aggregate rating of Moderate Buy based on 548 analyst ratings issued in the past year covering 31 companies (88.7% of the portfolio).SYNB Aggregate Price Target$30.63High Prediction$30.63Average Prediction$30.63Low Prediction$30.63Holdings in SYNB have an aggregate price target of $30.63 and a range of $30.63 to $30.63 covering 31 companies (88.7% of the portfolio).SYNB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy26 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Putnam BioRevolution ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 31 SYNB Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.53%TMOThermo Fisher Scientific$572.85+2.4%4.9742 of 5 stars2.86$648.95 13.3%22News CoveragePositive News6.19%DHRDanaher$244.18+2.4%4.8829 of 5 stars2.75$285.55 16.9%20Upcoming EarningsAnalyst ForecastPositive News5.88%BIOBio-Rad Laboratories$354.26+3.5%4.1034 of 5 stars2.60$394.20 11.3%5Positive News5.53%NVDANVIDIA$140.83+2.3%4.9513 of 5 stars2.95$164.63 16.9%43Positive News4.94%CTVACorteva$63.12+1.3%4.6931 of 5 stars2.68$65.59 3.9%19Analyst ForecastNews CoveragePositive News4.62%ABBVAbbVie$172.41+0.5%4.9964 of 5 stars2.88$205.50 19.2%24Positive News3.71%GOOGLAlphabet$198.05+1.0%4.1565 of 5 stars2.88$208.15 5.1%433.68%ASNDAscendis Pharma A/S$131.06+2.3%3.4834 of 5 stars2.93$192.07 46.6%14Analyst Revision3.64%AZNAstraZeneca$67.96+2.0%4.0417 of 5 stars3.00$89.75 32.1%10Analyst Revision3.64%DDDuPont de Nemours$78.43+1.2%4.7211 of 5 stars2.75$98.00 25.0%12Analyst Upgrade3.62%LLYEli Lilly and Company$741.98+2.2%4.9971 of 5 stars2.81$1,002.22 35.1%213.41%CDNSCadence Design Systems$310.97+1.8%4.6477 of 5 stars2.79$329.50 6.0%14Positive NewsGap Up3.31%EXASExact Sciences$54.26+4.9%4.8179 of 5 stars2.94$72.94 34.4%18News Coverage2.92%DARDarling Ingredients$35.42-3.3%4.0363 of 5 stars2.78$53.44 50.9%92.87%ZTSZoetis$167.50+1.0%4.8745 of 5 stars3.09$211.89 26.5%11Positive NewsHigh Trading Volume2.73%REGNRegeneron Pharmaceuticals$687.80+0.9%4.6173 of 5 stars2.65$1,015.38 47.6%232.43%NGVTIngevity$47.73+1.1%1.1807 of 5 stars2.50$52.17 9.3%6Gap Up2.34%AVTRAvantor$21.74-1.7%4.7984 of 5 stars2.77$27.38 26.0%13Analyst Forecast2.22%ONONON$60.01+3.5%2.3186 of 5 stars2.88$59.36 -1.1%24Analyst ForecastNews CoverageGap Up1.71%TWSTTwist Bioscience$50.45+6.1%2.9033 of 5 stars2.70$51.90 2.9%101.64%PPGPPG Industries$123.41+2.6%4.4299 of 5 stars2.53$149.23 20.9%15Dividend Announcement1.57%ARGXargenx$647.39+1.1%2.3342 of 5 stars2.86$658.39 1.7%22Gap Up1.54%TECHBio-Techne$78.75+3.9%4.1199 of 5 stars2.63$82.00 4.1%8News Coverage1.47%BMRNBioMarin Pharmaceutical$62.53+1.6%4.9978 of 5 stars2.74$94.20 50.6%231.43%VRTXVertex Pharmaceuticals$427.89+1.4%4.302 of 5 stars2.52$490.38 14.6%31Positive News1.18%MEDPMedpace$347.52+3.0%4.1215 of 5 stars2.45$380.56 9.5%111.07%BGBunge Global$78.64-1.1%4.675 of 5 stars2.75$115.14 46.4%8Analyst DowngradeNews Coverage1.04%ALNYAlnylam Pharmaceuticals$264.99+7.6%4.384 of 5 stars2.72$298.61 12.7%25Analyst ForecastGap Up0.90%RCKTRocket Pharmaceuticals$10.16-1.5%4.5072 of 5 stars2.92$47.27 365.3%120.45%LEGNLegend Biotech$34.67+6.2%2.7464 of 5 stars3.00$80.62 132.5%13Analyst ForecastGap Up0.44%CRSPCRISPR Therapeutics$41.51+2.4%2.5057 of 5 stars2.47$78.38 88.8%19Short Interest ↑Gap Up This page (NYSEARCA:SYNB) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Putnam BioRevolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Putnam BioRevolution ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
